NEXT Financial Group, Inc - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 91 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2021$1,0000.0%2000.0%0.00%
Q2 2021$1,0000.0%2000.0%0.00%
Q1 2021$1,0000.0%2000.0%0.00%
Q4 2020$1,0000.0%2000.0%0.00%
Q3 2020$1,0002000.0%0.00%
Q1 2020$0
-100.0%
2000.0%0.00%
Q4 2019$1,0002000.0%0.00%
Q3 2019$0
-100.0%
2000.0%0.00%
Q1 2019$1,0000.0%2000.0%0.00%
Q4 2018$1,000
-50.0%
2000.0%0.00%
-100.0%
Q3 2018$2,000
+100.0%
2000.0%0.00%
Q3 2017$1,000
-99.9%
2000.0%0.00%
Q2 2017$1,000,0000.0%2000.0%0.00%
Q1 2017$1,000,0002000.0%0.00%
Q4 2016$0
-100.0%
2000.0%0.00%
Q3 2016$1,0002000.0%0.00%
Q2 2016$02000.0%0.00%
Q1 2016$02000.0%0.00%
Q4 2015$0
-100.0%
2000.0%0.00%
Q3 2015$1,0002000.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q2 2021
NameSharesValueWeighting ↓
QVT Financial LP 16,013,540$39,233,0001.19%
ARMISTICE CAPITAL, LLC 1,940,000$4,753,0001.12%
DAFNA Capital Management LLC 234,000$573,0000.50%
Alpha Wave Global, LP 1,655,162$4,055,0000.43%
Telemetry Investments, L.L.C. 150,000$368,0000.21%
LADENBURG THALMANN FINANCIAL SERVICES INC. 5,294,945$12,972,0000.18%
SABBY MANAGEMENT, LLC 792,617$1,942,0000.11%
K2 PRINCIPAL FUND, L.P. 443,887$1,088,0000.10%
Anson Funds Management LP 105,085$257,0000.08%
DIALECTIC CAPITAL MANAGEMENT, LP 25,000$61,0000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders